SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021771-24-000140
Filing Date
2024-05-24
Accepted
2024-05-24 16:45:27
Documents
13
Period of Report
2024-05-23
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 RE: RESTATEMENT brt8k523.htm   iXBRL 8-K 26649
  Complete submission text file 0001021771-24-000140.txt   162937

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA brtx-20240523.xsd EX-101.SCH 3884
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE brtx-20240523_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE brtx-20240523_pre.xml EX-101.PRE 16057
16 EXTRACTED XBRL INSTANCE DOCUMENT brt8k523_htm.xml XML 4058
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 24985158
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)